These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9640479)

  • 1. Comparison of tacrolimus absorption in transplant patients receiving continuous versus interrupted enteral nutritional feeding.
    Murray M; Grogan TA; Lever J; Warty VS; Fung J; Venkataramanan R
    Ann Pharmacother; 1998 Jun; 32(6):633-6. PubMed ID: 9640479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective oral administration of tacrolimus in renal transplant recipients.
    Kimikawa M; Kamoya K; Toma H; Teraoka S
    Clin Transplant; 2001 Oct; 15(5):324-9. PubMed ID: 11678958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study.
    Tsapepas D; Saal S; Benkert S; Levine D; Delfin M; Cremers S; Amann S; Dadhania D; Kapur S; Aull M
    Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation.
    Sæves I; Line PD; Bremer S; Vethe NT; Tveit RG; Meltevik TJ; Bergan S
    Ther Drug Monit; 2014 Feb; 36(1):46-53. PubMed ID: 24081206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual administration of tacrolimus in a renal transplant patient.
    Romero I; Jiménez C; Gil F; Escuin F; Ramirez E; Fudio S; Borobia A; Carcas A
    J Clin Pharm Ther; 2008 Feb; 33(1):87-9. PubMed ID: 18211623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
    Min DI; Chen HY; Lee MK; Ashton K; Martin MF
    Pharmacotherapy; 1997; 17(3):457-63. PubMed ID: 9165550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
    Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
    Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
    Scholten EM; Cremers SC; Schoemaker RC; Rowshani AT; van Kan EJ; den Hartigh J; Paul LC; de Fijter JW
    Kidney Int; 2005 Jun; 67(6):2440-7. PubMed ID: 15882290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant pharmacokinetic profiling and tacrolimus requirements post-transplant.
    Campbell S; Hawley C; Irish A; Hutchison B; Walker R; Butcher BE; Ferrari P
    Nephrology (Carlton); 2010 Oct; 15(7):714-9. PubMed ID: 21040167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy.
    Velickovic-Radovanovic RM; Paunovic G; Mikov M; Djordjevic V; Stojanovic M; Catic-Djordjevic A; Cvetkovic T
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):505-10. PubMed ID: 20102364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.
    Oellerich M; Schütz E; Kanzow P; Schmitz J; Beck J; Kollmar O; Streit F; Walson PD
    Ther Drug Monit; 2014 Apr; 36(2):136-40. PubMed ID: 24452066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.